Second state in the USA stocks Impavido (miltefosine) for Leishmaniasis and off-label emergency use

South Carolina because the second state after Texas to participate in a non-charge consignment program from Profounda in an effort to make the drug more readily available in times of need. Having the product available at multiple sites will allow treatment to start sooner when needed.

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

 Impavido® (miltefosine) is an FDA-approved treatment for cutaneous,  mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO 

®

Contact Your Doctor or the CDC to Learn More about IMPAVIDO (miltefosine)

Impavido is a registered trademark of Knight Therapeutics Licensed exclusively to Profounda in the USA

© 2015 Profounda, Inc. 

For Emergencies
Call 911